Safety of tranexamic acid (TXA), even at higher doses, was upheld in a meta-analysis. Across 216 randomized trials in various medical disciplines, the incidence of thromboembolic events -- including ...

Although the association between thrombocytosis in iron deficiency anemia is understood, researchers studied the risk for thrombotic complications. Reactive thrombocytosis was observed in ...

Please provide your email address to receive an email when new articles are posted on . Tranexamic acid utilization did not increase the risk for thrombotic events in high-risk patients. Tranexamic ...

In a study recently published in the leading journal "Blood", Florian Moik and Cihan Ay from the Division of Hematology and Hemastasology of the Department of Medicine I of MedUni Vienna/Vienna ...

Major arterial or venous thrombotic complications, major adverse cardiovascular events, and symptomatic venous thromboembolism (VTE) occur frequently in the first 30 days after admission to the ICU ...

The study, wrote the researchers, offers insight into emerging and uncommon complications following chimeric antigen receptor (CAR) T-cell therapy. Although rare, patients should be monitored for ...

To predict a severe outcome in COVID-19 patients, innate immune cellular signals are analyzed, identifying two novel neutrophil subsets: LOX-1- and CD123-expressing CD10-CD64 +. Thromboembolic events ...

Thrombotic (clotting) and bleeding events are complications that may occur after surgery. With the aging population in the western world, there are more patients undergoing orthopedic surgery than ...

Use of the antifibrinolytic medication ‘narrowly exceeded’ noninferiority in VTE risk compared with placebo in noncardiac ...

Pooled patient data from 2 bivalirudin vs heparin trials is shedding a light on intraprocedural thrombotic events in the setting of STEMI and non–ST-elevation acute coronary syndromes. In particular, ...